NCT00185835View on ClinicalTrials.gov

Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

July 31, 2006

Conditions
Head and Neck CancerCarcinoma, Squamous Cell
Interventions
DRUG

ZD-1839

DRUG

Cisplatin

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

American Society of Clinical Oncology

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Stanford University

OTHER